Tuesday, July 3, 2012

Medical Device Companies are increasingly outsourcing

The United States accounts for half of the outsourced medical device clinical trials.  Companies are turning to India, China, Eastern Europe and Latin America to reduce the cost and amount of time it takes for a clinical trial to be conducted.  India and China are focused on heavily because of their regulatory expertise in addition to the low cost.  With a compound annual growth rate of 12.5% through 2018, revenue in the device clinical trial industry is expected to reach $7.4 billion according to Healthcare Packaging.

At Partnerships in Clinical Trials Asia 2012, Chandrashekhar Nimkar, Director, Global Supply Chain, Alvogen will be on hand to present Challenges and Opportunities for Sourcing from India examining many of the challenges that arise when outsourcing to India.  For more information on this session and the rest of the event, download the brochure here.  If you'd like to join us in Shanghai September 12-14, as a reader of this blog, when you register to join us and mention code XP1775BLOG, you'll save 15% off the standard rate!

Do you believe outsourcing to India and China brings up certain IP issues?  Why?  What can the clinical research industry do to change this?

No comments: